Answers are grounded in this paper and cite their sources.
In vitro mutational analysis reveals multi-site phosphorylation requirements for 14-3-3ζ binding in human tau protein, suggesting a mechanism regulating pathological filament formation.
Serine residues phosphorylated by protein kinase A (PKA) in the shortest isoform of human tau protein (tau3) were sequentially replaced by alanine and interaction of phosphorylated tau3 and its mutants with 14-3-3 was investigated. Mutation S156A slightly decreased interaction of phosphorylated tau3 with 14-3-3. Double mutations S156A/S267A and especially S156A/S235A, strongly inhibited interaction of phosphorylated tau3 with 14-3-3. Thus, two sites located in the Pro-rich region and in the pseudo repeats of tau3 are involved in phosphorylation-dependent interaction of tau3 with 14-3-3. The state of tau3 phosphorylation affects the mode of 14-3-3 binding and by this means might modify tau filament formation.
No takes yet. Share an insight, caveat, or question.
Sluchanko et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: